The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: a role for the adaptor protein Crk

Hepatocyte growth factor triggers a complex biological program leading to invasive cell growth by activating the c-Met receptor tyrosine kinase. Following activation, Met signaling is elicited via its interactions with SH2-containing proteins, or via the phosphorylation of the docking protein Gab1, and the subsequent interaction of Gab1 with additional SH2-containing effector molecules. We have previously shown that the interaction between phosphorylated Gab1 and the adaptor protein Crk mediates activation of the JNK pathway downstream of Met. We report here that c-Cbl, which is a Gab1-like docking protein, also becomes tyrosine-phosphorylated in response to Met activation and serves as a docking molecule for various SH2-containing molecules, including Crk. We further show that Cbl is similarly capable of enhancing Met-induced JNK activation, and several lines of experimentation suggests that it does so by interacting with Crk. We also show that both Cbl and Gab1 enhance Met-induced activation of another MAP kinase cascade, the ERK pathway, in a Crk-independent manner. Taken together, our studies demonstrate a previously unidentified functional role for Cbl in Met signaling and suggest that Met utilizes at least two docking proteins, Gab1 and Cbl, to activate downstream signaling pathways.

[1]  Y. Yazaki,et al.  Antisense Repression of Proto-oncogene c-Cbl Enhances Activation of the JAK-STAT Pathway but Not the Ras Pathway in Epidermal Growth Factor Receptor Signaling* , 1997, The Journal of Biological Chemistry.

[2]  J. Penninger,et al.  cbl-3: a new mammalian cbl family protein , 1999, Oncogene.

[3]  S. Corey,et al.  Involvement of Shc and Cbl-PI 3-kinase in Lyn-dependent proliferative signaling pathways for G-CSF , 2000, Oncogene.

[4]  Y. Yazaki,et al.  The Proto-oncogene Product c-Cbl Becomes Tyrosine Phosphorylated by Stimulation with GM-CSF or Epo and Constitutively Binds to the SH3 Domain of Grb2/Ash in Human Hematopoietic Cells (*) , 1995, The Journal of Biological Chemistry.

[5]  S. K. Shore,et al.  Tyrosine phosphorylation of C-Cbl facilitates adhesion and spreading while suppressing anchorage-independent growth of V-Abl-transformed NIH3T3 fibroblasts , 1999, Oncogene.

[6]  W. Birchmeier,et al.  Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis , 1996, Nature.

[7]  H. Band,et al.  Molecules in focus: The c-Cbl oncoprotein , 1998 .

[8]  W. Birchmeier,et al.  Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Bowtell,et al.  The Cbl protooncoprotein stimulates CSF‐1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation , 1999, The EMBO journal.

[10]  B. Druker,et al.  The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. V. Vande Woude,et al.  Met-HGF/SF: tumorigenesis, invasion and metastasis. , 2007, Ciba Foundation symposium.

[12]  A. Bardelli,et al.  Induction of epithelial tubules by growth factor HGF depends on the STAT pathway , 1998, Nature.

[13]  A. Bardelli,et al.  Specific Uncoupling of GRB2 from the Met Receptor , 1996, The Journal of Biological Chemistry.

[14]  Sakae Tanaka,et al.  c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption , 1996, Nature.

[15]  S. Shoelson,et al.  The SH3 Domain-binding T Cell Tyrosyl Phosphoprotein p120 , 1995, The Journal of Biological Chemistry.

[16]  A. Godwin,et al.  A Grb2-associated docking protein in EGF- and insulin-receptor signalling , 1996, Nature.

[17]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[18]  T. Hirano,et al.  Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors. , 1999, Blood.

[19]  Francesco Pagano,et al.  Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours , 1998, Oncogene.

[20]  C. Cooper,et al.  Molecular cloning of a new transforming gene from a chemically transformed human cell line , 1984, Nature.

[21]  M. Fiscella,et al.  Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor , 1998, Oncogene.

[22]  C. Cooper,et al.  Mechanism of met oncogene activation , 1986, Cell.

[23]  R. Baron,et al.  Ligand-induced Ubiquitination of the Epidermal Growth Factor Receptor Involves the Interaction of the c-Cbl RING Finger and UbcH7* , 1999, The Journal of Biological Chemistry.

[24]  M. Matsuda,et al.  Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells , 1993, Molecular and cellular biology.

[25]  G. Rodrigues,et al.  Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase , 1993, Molecular and cellular biology.

[26]  A. Bardelli,et al.  Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential , 1997, Oncogene.

[27]  W. Langdon,et al.  Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. , 1994, The EMBO journal.

[28]  M. Shibuya,et al.  Two species of human CRK cDNA encode proteins with distinct biological activities , 1992, Molecular and cellular biology.

[29]  M. Nau,et al.  cbl-b inhibits epidermal growth factor receptor signaling , 1999, Oncogene.

[30]  M. Matsuda,et al.  CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells , 1994, Molecular and cellular biology.

[31]  Y. Yarden,et al.  The RING Finger of c-Cbl Mediates Desensitization of the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[32]  M. Tremblay,et al.  Association of the Multisubstrate Docking Protein Gab1 with the Hepatocyte Growth Factor Receptor Requires a Functional Grb2 Binding Site Involving Tyrosine 1356* , 1997, The Journal of Biological Chemistry.

[33]  M. Czech,et al.  Interactions of Cbl with Grb2 and phosphatidylinositol 3'-kinase in activated Jurkat cells , 1995, Molecular and cellular biology.

[34]  W. Langdon,et al.  Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl , 1997, Oncogene.

[35]  L. Schmidt,et al.  Activating mutations for the met tyrosine kinase receptor in human cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Shoelson,et al.  Stimulation through the T Cell Receptor Induces Cbl Association with Crk Proteins and the Guanine Nucleotide Exchange Protein C3G (*) , 1996, The Journal of Biological Chemistry.

[37]  A. Bardelli,et al.  A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family , 1994, Cell.

[38]  H. Band,et al.  The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction. , 1997, Critical reviews in oncogenesis.

[39]  S. Ōmura,et al.  Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway , 1997, Molecular and cellular biology.

[40]  M. E. Cook,et al.  Regulation of β1-integrin-mediated cell adhesion by the CbI adaptor protein , 1998, Current Biology.

[41]  A Ciechanover,et al.  Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. , 1999, Molecular cell.

[42]  W. Marston Linehan,et al.  Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas , 1998, Nature Genetics.

[43]  Y. Yazaki,et al.  c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway. , 1998, Blood.

[44]  E. Ruoslahti,et al.  Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases , 1996, Molecular and cellular biology.

[45]  Keigo Nishida,et al.  Gab1 Acts as an Adapter Molecule Linking the Cytokine Receptor gp130 to ERK Mitogen-Activated Protein Kinase , 1998, Molecular and Cellular Biology.

[46]  M. Matsuda,et al.  Emerging components of the Crk oncogene product: the first identified adaptor protein. , 1996, Cellular signalling.

[47]  S. Feller,et al.  Physiological signals and oncogenesis mediated through Crk family adapter proteins , 1998, Journal of cellular physiology.

[48]  K. Vuori,et al.  The adaptor protein Crk connects multiple cellular stimuli to the JNK signaling pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  W. Birchmeier,et al.  Signaling of Hepatocyte Growth Factor/Scatter Factor (HGF) to the Small GTPase Rap1 via the Large Docking Protein Gab1 and the Adapter Protein CRKL* , 2000, The Journal of Biological Chemistry.

[50]  Z. Kam,et al.  c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.

[51]  K. Vuori,et al.  CAS/Crk Coupling Serves as a “Molecular Switch” for Induction of Cell Migration , 1998, The Journal of cell biology.

[52]  B. Mayer,et al.  Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins , 1995, Molecular and cellular biology.

[53]  Aaron Ciechanover,et al.  The ubiquitin–proteasome pathway: on protein death and cell life , 1998, The EMBO journal.

[54]  C. Lowell,et al.  A β1 integrin signaling pathway involving Src‐family kinases, Cbl and PI‐3 kinase is required for macrophage spreading and migration , 1998, The EMBO journal.

[55]  J. Schlessinger,et al.  Activation of the JNK pathway is essential for transformation by the Met oncogene , 1997, The EMBO journal.

[56]  M. Barbacid,et al.  Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation , 1997, Oncogene.

[57]  D. Kamikura,et al.  Efficient Cellular Transformation by the Met Oncoprotein Requires a Functional Grb2 Binding Site and Correlates with Phosphorylation of the Grb2-associated Proteins, Cbl and Gab1* , 1997, The Journal of Biological Chemistry.

[58]  K. Vuori,et al.  Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1 – Crk signaling complex formation , 1999, Oncogene.

[59]  T. Hunter,et al.  The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. , 1999, Science.

[60]  A. Wong,et al.  Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.